ELEVAI Labs Announces New Exclusive Philippines Distributor Partnership

Last Updated: 29.1.2024 20:01

Dmark Multisales Corp. is a Prominent Marketing and Distribution Company Based in the Philippines With Over 20 Years of Industry Experience

ELEVAI Labs, a medical aesthetic biotechnology company focused on physician-dispensed skincare and a leader in exosome research and development, is pleased to announce its new partnership with Dmark Multisales Corporation, a prominent marketing and distribution company based in the Philippines. This strategic collaboration will see Dmark Multisales Corp. become the official distributor of ELEVAI’s range of exosome products throughout the Philippine market.

Nikki Tang, CEO of Dmark Multisales Corp, had the following to say about the new partnership with ELEVAI Labs:

“We are absolutely thrilled to work with a strong partner like ELEVAI Labs, Inc. Their products adhere to the highest safety and quality standards, making them the gold standard in the exosome space. We are looking forward to a long-lasting relationship and bringing their cutting-edge solutions to our valued customers in the Philippines.”

The partnership marks an exciting milestone for both companies. Dmark Multisales Corp. boasts over 20 years of experience in the marketing and distribution industry, positioning them as a leading authority in the field. With a wealth of knowledge and expertise, they have successfully established themselves as a reputable company in the aesthetic and medical aesthetics arena across South East Asia. Both companies are confident that this collaboration will bring immense value to aesthetic professionals and patients alike, ultimately transforming the landscape of exosome-based technology in the region.

Commenting on the collaboration, Chris Kraneiss, Chief Commercial Officer at ELEVAI, said:

“The announcement of Dmark Multisales Corp. as our representative in the Philippines comes with great pride knowing that they are one of the most successful, credible and reputable companies in the medical aesthetics arena in South East Asia. ELEVAI’s product portfolio fits excellently with Dmark’s existing energy-based device brands, such as Alma Lasers, Asclepion, Lumenis, and Pollogen. We firmly believe that with their support, ELEVAI will achieve significant success in the Philippines, further expanding our footprint in South East Asia.”

For more information, visit the ELEVAI Skincare website here.

Interested in buying ELEVAI Skincare products? Click here to find an authorized ELEVAI Skincare Professional.

View the original ELEVAI Labs press release here.

????Join the Discussion in the Wealthy VC Investor Group

????Have a Stock Tip or New  Story Suggestion? Email us at Invest@WealthyVC.com

Elevai Labs Inc. is a paid client of Wealthy VC.

Wealthy VC’s parent company has been compensated $13,500 per month for 12 months for investor relations, public relations, and market awareness services by Elevai Labs Inc.

This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.

View Full Disclaimer Here